Patents by Inventor Alfredo Acosta

Alfredo Acosta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082153
    Abstract: The present invention relates to a formulation of Ivermectin in oral solution which allows proper absorption, enabling the drug to be consumed at any time. In particular, the oral lipid composition is designed with the appropriate selection of a medium-chain triglyceride oil, a hydrophilic cosolvent and an antioxidant, so as to influence the absorption/digestibility of the poorly water-soluble active ingredient and facilitate bioavailability and bioactivity for the administration of the oral solution in drops. The formulation includes Ivermectin in a lipid medium including a cosolvent and an antioxidant in combination with an oily solvent to form an oral solution for administration in drops. The field of the invention is related to improving the bioavailability of insoluble drugs such as Ivermectin for administration in oral drop forms based mainly on lipids without compromising stability or creating impurities.
    Type: Application
    Filed: December 30, 2020
    Publication date: March 14, 2024
    Inventors: Carlos Manuel Padilla Botett, Diego Rafael Monterroza Hernandez, Janice Garcia Vera, Jose Alfredo Acosta Urrea, Alfredo Berthel Beleño
  • Publication number: 20230405034
    Abstract: The present invention relates to a formulation of Ivermectin in soft capsules. In particular, the present invention relates to a formulation of Ivermectin in soft capsules which allows proper absorption in water, allowing the drug to be consumed at any time. Ivermectin, as an insoluble active ingredient, according to the invention, can be formulated in a liquid solution without compromising its stability and without creating impurities to form a suitable soft gelatin capsule. Therefore, the invention comprises a formulation comprising Ivermectin in a lipid medium which includes a surfactant in combination with an oily solvent, a co-surfactant and an oxidant, to form a soft capsule comprising a collagen coating, a plasticiser and gelatin. The field of the invention relates to improving the bioavailability of insoluble drugs such as Ivermectin for delivery in oral soft gelatin capsule forms.
    Type: Application
    Filed: September 30, 2020
    Publication date: December 21, 2023
    Inventors: Diego Rafael Monterroza Hernandez, José Alfredo Acosta Urrea, Rafael Fabián Domínguez Borja, Yudis Esther Gomez Tapia, Alfredo Berthel Beleño
  • Patent number: 5770974
    Abstract: The present invention solves the gain, noise figure, and distortion problems of prior art thermal compensation circuits by incorporating a temperature-compensating circuit in the feedback loop of a transistor amplifier arrangement. Using this method, the insertion loss is reduced as the gain of the amplifier varies proportionately to the temperature. This method has a negligible effect on the noise figure and distortion, and the incremental cost is much lower than the conventional circuits. Furthermore, the present invention can be used in both single-ended or push-pull dual amplifier configurations.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: June 23, 1998
    Assignee: Scientific-Atlanta, Inc.
    Inventors: Stephan W. Vogt, John W. Brickell, Alfredo Acosta